Related Experiment Video
Updated: Apr 6, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.4K
A novel highly sensitive and specific flow cytometry system for cervical cancer screening
Xiaotian Han1, Bo Ping2, Masakatsu Morita3
1Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, PR China.
Gynecologic Oncology
|July 28, 2015
Summary
A novel flow cytometry (FCM) cervical cancer screening system demonstrated high sensitivity and specificity, comparable to human papillomavirus (HPV) testing. The FCM system
Area of Science:
- Gynecologic Oncology
- Diagnostic Cytology
- Biomedical Engineering
Background:
- Cervical cancer screening is crucial for early detection and prevention.
- Traditional methods like Papanicolaou smears and HPV testing have limitations.
- Novel screening technologies are needed to improve accuracy and efficiency.
Purpose of the Study:
- To evaluate the performance of a new flow cytometry (FCM) based cervical cancer screening system.
- To compare the FCM system's efficacy against the established human papillomavirus (HPV) Hybrid Capture 2 (HC2) test.
- To assess the quantitative potential of FCM in disease severity evaluation.
Main Methods:
- A cohort of Chinese women aged 20 years and older were enrolled.
- Participants underwent gold standard cytology/pathology, HPV HC2 testing, and FCM testing.
- FCM analysis included the cell proliferation index (CPIx) for disease assessment.
Main Results:
- The FCM system showed a sensitivity of 87.6% and specificity of 90.5%.
- HPV HC2 testing yielded a sensitivity of 89.7% and specificity of 84.5%.
- FCM specificity was statistically superior to HPV HC2 (p=0.04), with increasing CPIx correlating with disease severity.
Conclusions:
- The FCM screening system exhibits high sensitivity and specificity across various age groups.
- FCM technology offers a promising alternative for cervical cancer screening.
- The FCM system's quantitative CPIx provides valuable insights into disease progression.
